Data on Combo Therapy for Multiple Myeloma to Be Presented by PharmaMar at ASCO Meeting
Positive data for the Phase 1 trial of PharmaMar’s plitidepsin combined with bortezomib and dexamethasone for the treatment of relapsed and/or refractory multiple myeloma will be presented at the 52nd Congress of the American Society of the Clinical Oncology (ASCO) June 3-7  in Chicago. Dr. MarÃa Victoria Mateos, M.D., of the Hematological…